Zydus Lifesciences Ltd.

Zydus Lifesciences Limited is a global pharmaceutical company headquartered in Ahmedabad, India. 

It is a leading player in the generics market and has been at the forefront of developing new and innovative pharmaceutical products. 

It is a fully integrated company, with a presence in the research and development, manufacturing, marketing, and distribution of pharmaceutical products.

Business Segment

Zydus has three main business segments: 

• Generics: includes a range of generic products, including oral formulations, injectable formulations, and topical formulations 
• Specialty formulations: offers a range of specialty formulations that require specialized manufacturing, such as transdermal patches, controlled-release tablets, and sustained-release capsules 
• Biologics: Biologics are complex products that are derived from living organisms. The pharma company develops a range of biologics, such as biosimilars and vaccines 
• Product Portfolio: Cadabolic injection, Bilypsa tablets 4MG, Ampilox DS 500/500 MG, Fusys 150 MG Tablet 1, and ATEN 25 MG Tablet 14 among others

Geographical Presence

The company’s global business has a strong presence in the regulated markets of the US, Europe, and in the high-profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide.